Nancy Hamzo

Nancy Hamzo

Baker & McKenzie LLP


Nancy Hamzo is a partner in the Corporate and Securities Practice Group in Toronto. Nancy has also practiced in the Firm's Chicago office. She advises clients on a wide range of corporate transactional matters and Canadian antitrust and foreign investment matters.

Nancy is a member of Baker McKenzie's North America Steering Committee for Cross-Border Transactions and Integrations as well as a member of the Global Healthcare group. She also co-chairs the Women's Networking Initiative in the Toronto office.

Practice Focus

Nancy advises clients on a broad range of corporate transactions, particularly on cross-border mergers, acquisitions and multi-jurisdictional reorganizations, including pre-transaction restructurings, post-acquisition integrations and spin-offs. She also routinely advises on antitrust/competition and foreign investment requirements in Canada.

Representative Legal Matters

Corporate Transactional

  • Advised Brookfield Business Partners L.P. on all non-US legal matters and implementation of its USD 13.2 billion acquisition of the Power Solutions business of Johnson Controls International.

  • Represented Camso Inc. on its USD 1.7 billion sale to The Michelin Group. The transaction spanned over 28 jurisdictions.

  • Advised a global biotechnology company on a post-acquisition integration matter involving over 70 jurisdictions.

  • Advised Baxter International Inc. on the international aspects of the spinoff of its bioscience business into a new NYSE-listed company, Baxalta Incorporated.

  • Advised on the Canadian legal implementation of the separation of Abbott Laboratories' research-based pharmaceuticals business which included the portfolio of proprietary pharmaceuticals and biologics into AbbVie Corporation.

  • Advised Abbott Laboratories in Canada in connection with its post-acquisition integration with Solvay S.A.

Antitrust and Foreign Investment

  • Represented Camso Inc. on the merger control and foreign investment filings required in connection with its sale to The Michelin Group.

  • Advised a state-owned enterprise on merger control, foreign investment and other regulatory approvals worldwide for its acquisition of control of the former Canadian monopoly grain marketing board through a joint venture with a US-based global agribusiness and food company.

  • Represented Dentsu Inc., a Japanese advertising and public relations company, in obtaining Canadian merger clearance for its CAD 5 billion acquisition of UK-based media and digital marketing communications firm Aegis plc.

  • Advised Prestige Brands Inc. on the Canadian merger control aspects of its CAD 660 million acquisition of substantially all the North American OTC product portfolio of GlaxoSmithKline plc, through a competitive auction.

Professional Honors

  • Recognized as a Lexpert "Rising Star: Leading Lawyer Under 40" in Canada, 2017


  • Ontario~Canada (2008)


  • University of Ottawa (J.D.) (2008)
  • University of Ottawa (Bachelor of Commerce with Honors)


  • Arabic
  • English


Moderator, "Transforming Enterprises: Unlocking Value Through Spin-Offs," Bloomberg BNA & Baker McKenzie conference, 2016-2017


Co-author, Canada: Pharmaceuticals, "The Antitrust Review of the Americas 2017," Global Competition Review, September 2016